These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 8034506)

  • 21. Progress toward global measles control and elimination, 1990-1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Sep; 46(38):893-7. PubMed ID: 9315780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measles epidemiology and outbreak response immunization in a rural community in Peru.
    Sniadack DH; Moscoso B; Aguilar R; Heath J; Bellini W; Chiu MC
    Bull World Health Organ; 1999; 77(7):545-52. PubMed ID: 10444877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measles epidemiology and elimination strategies in Turkey.
    Güriş D; Bayazit Y; Ozdemirer U; Buyurgan V; Yalniz C; Toprak I; Aycan S
    J Infect Dis; 2003 May; 187 Suppl 1():S230-4. PubMed ID: 12721918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress toward measles control - African region, 2001-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(37):1036-41. PubMed ID: 19779399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measles in Jordan: a prototype of the problems with measles in developing countries.
    Khuri-Bulos NA
    Pediatr Infect Dis J; 1995 Jan; 14(1):22-6. PubMed ID: 7715984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Measles outbreak in the province of Córdoba, Argentina, in 1998].
    Isa MB; González M; Martínez LC; Giordano MO; López De Neira MJ; Passeggi C; De Wolff MC; Nates SV
    Rev Argent Microbiol; 1999; 31(2):90-5. PubMed ID: 10425666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Epidemiology and prevention of measles in the United States: 30 years of vaccination].
    Chauvin P
    Rev Epidemiol Sante Publique; 1995; 43(1):61-71. PubMed ID: 7892518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should outbreak response immunization be recommended for measles outbreaks in middle- and low-income countries? An update.
    Cairns KL; Perry RT; Ryman TK; Nandy RK; Grais RF
    J Infect Dis; 2011 Jul; 204 Suppl 1():S35-46. PubMed ID: 21666184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update: global measles control and mortality reduction--worldwide, 1991-2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 May; 52(20):471-5. PubMed ID: 12807081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress in global measles control, 2000-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Feb; 61(4):73-8. PubMed ID: 22298303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mass measles control in West and Central Africa.
    Foster SO; Pifer JM
    Afr J Med Sci; 1971 Apr; 2(2):151-8. PubMed ID: 5111614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scheduling of measles vaccination in low-income countries: projections of a dynamic model.
    Bauch CT; Szusz E; Garrison LP
    Vaccine; 2009 Jun; 27(31):4090-8. PubMed ID: 19410622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress toward measles elimination--European Region, 2005--2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Feb; 58(6):142-5. PubMed ID: 19229166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of alternative approaches to accelerated measles control: experience in the African region, 1996-2002.
    Otten MW; Okwo-Bele JM; Kezaala R; Biellik R; Eggers R; Nshimirimana D
    J Infect Dis; 2003 May; 187 Suppl 1():S36-43. PubMed ID: 12721884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress toward measles elimination in Germany.
    Hellenbrand W; Siedler A; Tischer A; Meyer C; Reiter S; Rasch G; Teichmann D; Santibanez S; Altmann D; Claus H; Kramer M
    J Infect Dis; 2003 May; 187 Suppl 1():S208-16. PubMed ID: 12721915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of measles elimination strategies in the United States.
    Hinman AR; Orenstein WA; Papania MJ
    J Infect Dis; 2004 May; 189 Suppl 1():S17-22. PubMed ID: 15106084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Jul; 120(1):221-31. PubMed ID: 17606582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update: measles--United States, January-July 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Aug; 57(33):893-6. PubMed ID: 18716580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology and prevention of measles.
    Atkinson WL
    Dermatol Clin; 1995 Jul; 13(3):553-9. PubMed ID: 7554503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.